Medical aesthetic specialist Jetema announced on the 13th that it signed a memorandum of understanding (MOU) with global premium wellness brand Bellezzi on the 10th for exclusive domestic distribution rights.
This agreement was created to combine the expertise and technological prowess of both companies to provide a pleasant and comfortable environment for both medical practitioners and patients.
Under the agreement, Bellezzi will supply Jetema with its high-end flagship products, including its "Wellness Beds" and "Treatment Chairs," both of which are recognized as premium brands in the European market. These products are optimized for facial and body treatments, offering patients comfort and enhancing efficiency and safety for practitioners.
Jetema has been strengthening its competitiveness in the domestic and international aesthetic medicine markets based on high-quality products such as the botulinum toxin "Zetemadertoxin" and the hyaluronic acid filler "Epitique." Through this agreement, Jetema plans to expand its service scope into new business areas aimed at improving the premium medical environment.
A Jetema representative stated, “Our collaboration with Bellezi will contribute to the creation of a premium medical and wellness environment, while also enhancing Jetema’s brand value.”
- See more related articles
You must be logged in to post a comment.